Irving, Texas, September 2025 — Revision Skincare®, a leader in advanced skincare solutions, has announced the appointment of Lisa Paley as its new Chief Executive Officer. A highly experienced, transformational leader, Paley brings nearly three decades of executive experience across some of the world’s leading consumer healthcare companies, including Haleon, GSK, Pfizer, and Johnson & Johnson.
“Lisa’s extensive experience building science-backed brands across the consumer health, wellness and beauty spectrum makes her the ideal leader to accelerate our business in the US and key global markets,” said Matt Farron, Partner, Co-Head of Consumer Group at Gryphon Investors. “She has a stellar reputation as a visionary leader who can deliver sustained growth, scale innovation across geographies and build high-performance cultures with an engaging, people-driven leadership style. We’re thrilled to welcome Lisa to lead Revision Skincare’s next stage of growth.”
As professional and consumer health and beauty trends continue to intersect, Paley will leverage her expertise building powerhouse consumer brands to reinvigorate Revision Skincare’s business and unlock its full potential. She joins the company from Haleon, the world’s largest global consumer health company, where she served as President of North America and was a founding member of the Executive Leadership Team. During her tenure, she led the company’s North American business through its landmark corporate spin-off from GSK and its public listings on both the NYSE and FTSE.
“I’m honored to join Revision Skincare as CEO at such an exciting time in the beauty industry, when we’re seeing consumer health and beauty trends converge in new ways,” said Lisa Paley. “Our brand has a powerful foundation of scientific innovation and proven results, and I look forward to building on that legacy to bring even more transformative skin health solutions to professionals and consumers. At Revision, we believe beauty and confidence come from skin that’s nurtured for the long term, and my goal is to extend our impact while staying true to our mission of delivering trusted, physician-dispensed skincare.”
At Haleon, and previously at GSK Consumer Healthcare (a joint venture with Pfizer), Paley delivered category-leading performance across iconic brands while pioneering advancements in AI-driven marketing, e-commerce, strategic revenue management, and organizational culture and engagement. Before GSK, she held progressively senior roles at Pfizer Consumer Healthcare, ultimately serving as President, North America, with P&L responsibility over the US, Canada, and the Caribbean. She also served as Vice President of US Sales at Johnson & Johnson. A former Certified Public Accountant, Paley began her career at Deloitte. She holds a BS in Accounting from Miami University and an Executive MBA from The Ohio State University.
Over her career, Paley has also contributed her leadership to industry organizations. She previously served as Chairman of the Board of the Consumer Healthcare Products Association (CHPA), led the National Association of Chain Drug Stores (NACDS) Retail Advisory Board, and has been a board member of NextUp, Excel Share Group, and WE, an organization dedicated to expanding women’s voices in consumer health and wellness.
About Revision Skincare®
Revision Skincare® is committed to developing and providing effective, high-quality skincare products that deliver real results. With a focus on innovation and science, the company offers a comprehensive range of products designed to enhance skin health and beauty.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
